Glycoproteins were subjected to reduction (dithiothreitol), alkylation (iodoacetamide) and overnight tryptic digestion in the presence of 2,2,2-trifluoroethanol (5%) as denaturant, and ammonium bicarbonate (100 mM) as pH buffer. Reactions were stopped by heating at 95⁰ C for 5 min. The masses of resulting peptides were analyzed using a Bruker Ultraflextreme MALDI MS (Bruker Daltonics, Billerica, MA) using 2,5-dihydroxybenzoic acid (DHB) as matrix. The samples were then dried down in a centrifugal evaporator.
started from 98% solvent A to 15% solvent A over 30 min. The solvent conditions were then changed to 5% solvent A in the next 2 min and kept constant for 5 min thereafter to wash the columns. The columns were brought back to the starting condition, 98% solvent A, in 3 min and then equilibrated for 5 min.
For the HILIC-C18 chip, the HPLC conditions were as follows. Solvent A was 99% water, 1% acetonitrile with 0.1% formic acid. Solvent B was 99% acetonitrile, 1% water with 0.1% formic acid. A premixed special loading solvent, 80% acetonitrile, 20% water, modified with 0.1% trifluoroacetic acid, was delivered using the loading pump in this case as the loading condition. The samples were loaded and washed on the trapping column using the loading pump with 4µL of the special loading solvent. These high organic conditions were used to allow binding of the glycosylated peptides to the HILIC trapping column which the non-glycosylated peptides were washed away to waste. The analytical column was equilibrated with the regular mobile phases at 98% solvent A. After the washing step was complete, the trapping column was brought in-line with the analytical column and the setup received flow from the nanoscale analytical pump, which delivered 98% solvent A for the first 10 min. These high-aqueous conditions allowed elution of the glycosylated peptides from the HILIC trapping column and binding to the C18 reversed phase analytical column. After this a gradient was delivered by the analytical pump to resolve and elute the glycopeptides from the C18 analytical column. The gradient was similar to that used in the C18 chip setup. Mobile phase was changed from 98% solvent A to 15% solvent A over 30 min. The solvent conditions were then changed to 5% solvent A in the next 2 min and kept constant for 5 min thereafter to wash the columns. The columns were brought back to the starting condition, 98% solvent A, in 3 min and then equilibrated for 5 min.
Both HPLC chips (C18 and HILIC-C18) consisted of an integrated nano-ESI source, to allow sample introduction into the mass spectrometer. The MS and tandem MS conditions used for both C18 and HILIC-C18 runs were the same. Data dependent tandem mass spectra were acquired for the first 40 minutes of the run. Top 5 most abundant, multiply charged precursor ions were selected for fragmentation with dynamic exclusion enabled after 10 spectra for each precursor. MS spectra were acquired in the 200-2000 m/z range and MS/MS spectra in the 50-3000 m/z range. MS and MS/MS spectra were acquired at rates of 4 and 1 spectra/s, respectively. An isolation width of 4 m/z was used. Nitrogen was used as the collision gas and collision energy varied with precursor m/z. The collision energy was determined dynamically as a linear function of precursor m/z, with a slope of 5 and offset of -4.8 to yield peptide backbone fragments. For only glycan dissociation, a lower collision energy can be used, also calculated using the precursor m/z, with a slope of 0.9 and offset of 2. Data were acquired in the positive ion mode with source capillary voltage set at 2150 V for the first 40 minutes of the run. Drying gas flow was 13 l/min for the first 25 minutes and 11 l/min, thereafter with gas temperature set at 225⁰C throughout the run. Data files were acquired using Agilent MassHunter Workstation Data Acquisition software and analyzed using Agilent MassHunter Qualitative Analysis software package.
Online HILIC enrichment setup on 2.1mm column scale
To demonstrate that the use of online HILIC enrichment setup prior to reversed phase separation is not limited to the chip platform, we carried our glycopeptide enrichment and separation on an LC system consisting of a 4.6mm ID guard column driven by an LC pump, an external valve to interface the guard column to the separation column, and a 2.1 mm ID separation column driven by a second LC pump. Specifically, glycopeptides were enriched using a 4.6 mm x 1.0 cm Amide-80 guard column (5 μm Amide-80, Tosoh) flowing at 500 μL min -1 with a solvent composition of 80% ACN 0.1% TFA. After enrichment, the external valve was triggered and glycopeptides were separated using two 2.1 mm x 10 cm 300 SB-C18 columns (1.8μm, Agilent Technologies) connected in series. The separation gradient was supplied by a 1290 binary LC (Agilent Technologies) at a flow rate of 200 μL min -1
. Solvent A was 0.1% formic acid in water and solvent B was 0.1% formic acid in acetonitrile. Glycopeptides were separated by gradient that reached 42% B in 20 minutes. The separation was performed on-line with a 6550 QTOF (Agilent Technologies). Five μL of a 2 pmol μL -1 tryptic digest of transferrin was injected onto the LC/MS system.
The resulting LC-MS chromatogram has been presented in figure S-4. Transferrin, AGP and hemagglutinin were subjected to theoretical digestion using trypsin with up to 2 missed cleavages and carbamidomethyl as the constant modification. Asparagine deamidation was used as the variable modification for hemagglutinin only. For transferrin and AGP, known glycopeptides were combined with a list of glycans to generate theoretical glycopeptides. For HA, the NetNGlyc 1.0 server (http://www.cbs.dtu.dk/services/NetNGlyc) was used to predict glycosylation sites. The m/z's from data files were matched to the theoretical neutral mass lists within an error tolerance of +/-10 ppm.
The lists of glycopeptides/peptides for each glycoprotein studied have been provided, as Table S -1 with the number of glycosylation sites/sequons considered as occupied on the glycopeptides. The masses of peptides listed below are for neutral peptides. The possible glycans considered occupying each sequon are listed in Table S Peptide fragment ion mass tables for HILIC-C18 LC-MS/MS of glycopeptides identified and presented in Table 2 . 
